TEAM
Thomas F. Krol, PharmD, CLP
Chief Executive Officer
Dr. Krol is a pharmacist, scientist and entrepreneur with experience in biopharma, drug delivery and life sciences. He began is career as a clinical scientist in big pharma with companies such GSK, Sanofi and Pfizer, and has developed startups for the last 20 years as founder and executive. He serves on numerous boards and supports the life science startup ecosystem.
He brings to STAT Therapeutics significant experience in technology development and business partnering to pursue his passion of bringing new technologies to people who could benefit from them.
Dr. Krol holds a BS in pharmacy from Ferris State University, PharmD and Residency at University of Utah and fellowship at University of North Carolina.
Follow Dr. Krol on LinkedIn
Bryan Beutel, MD, FAAOS
Advisor
Dr. Beutel is a board-certified, fellowship-trained orthopaedic surgeon specializing in conditions of the upper extremity. He is an Assistant Professor at Kansas City University College of Medicine in Kansas City, MO, and he practices clinically at Sano Orthopedics in Lee’s Summit, MO.
Dr. Beutel completed his orthopaedic surgery residency at the NYU Hospital for Joint Diseases, during which time he also completed an orthopaedic research fellowship through their six-year Clinician-Scientist Training Program. Following residency, he completed a hand surgery fellowship at Mount Sinai Beth Israel in New York City. His research has been published extensively and presented at local, national, and international conferences.
In addition to medical and surgical training, Dr. Beutel brings expertise to STAT Therapeutics in arm anatomy and plays a pivotal role in optimizing the Drug Cuff™ injection site.
Follow Dr. Beutel on LinkedIn
Steve O’Connor, PhD
Advisor, Chief Technology Officer
Dr. O’Connor is a seasoned entrepreneur with extensive experience in the life sciences industry. Over the past 25 years, he has co-founded numerous companies, including Clinical Micro Sensors in 1995, acquired by Motorola Life Sciences in 2000 for $320M, now marketed by GenMark Diagnostics (NASDAQ:GNMK). In 2000, he founded Nanostream, a life-science tools drug discovery company that raised ~$37M in venture capital and sold products to nearly every major pharmaceutical company in the world.
He brings to STAT Therapeutics significant experience in technology development, intellectual property, fundraising, business partnering, and company building.
Dr. O’Connor holds a Ph.D. in Physical Chemistry from Caltech.
Follow Dr. O’Connor on LinkedIn